Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Targeting the intestinal L-cell for obesity and type 2 diabetes treatment
Nicolai Jacob Wewer Albrechtsen
,
Rune Ehrenreich Kuhre
,
Carolyn F. Deacon
,
Jens Juul Holst
*
*
Corresponding author for this work
Faculty of Health and Medical Sciences
Department of Biomedical Sciences
Endocrinology and Metabolism
Department of Biomedical Sciences
22
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting the intestinal L-cell for obesity and type 2 diabetes treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Glucagon-like
100%
Type 2 Diabetes Prevention
100%
Obesity
100%
Intestinal L Cells
100%
L-cells
60%
Appetite Regulation
40%
Hormone Secretion
20%
Type 2 Diabetes Mellitus (T2DM)
20%
Additive Effect
20%
Endogenous Hormones
20%
Cutting-edge Research
20%
Degradation-resistant
20%
Proglucagon-derived Peptides
20%
Peptide YY
20%
Dipeptidyl peptidase-4 (DPP-4)
20%
Cholecystokinin
20%
Oxyntomodulin
20%
Glucose Regulation
20%
Glicentin
20%
Cell Targeting
20%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
100%
Enzyme
20%
Dipeptidyl Peptidase-4
20%
Cholecystokinin
20%
Enhancer Region
20%
Agonist
20%
Enteroglucagon
20%
Peptide YY
20%
Secretion (Process)
20%
Hormone Release
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glicentin
20%
Proglucagon
20%